Drug intelligence / Profile preview

Arcofolin

Development stage
Unknown
Lead developer
Merck KGaA
Modality
Small Molecules
Administration
Oral
01

Overview

Arcofolin is a proprietary sodium salt of (6S)-5-methyltetrahydrofolic acid (5-MTHF), which is the primary biologically active form of folate found in human circulation. Developed by **Merck KGaA**, Arcofolin serves as a highly soluble and bioavailable alternative to synthetic folic acid. Unlike folic acid, which requires multi-step enzymatic reduction by dihydrofolate reductase (DHFR) and methylenetetrahydrofolate reductase (MTHFR) to become active, Arcofolin is immediately available for cellular utilization. This makes it particularly effective for individuals with MTHFR genetic polymorphisms who may have a reduced ability to process folic acid. It is utilized in dietary supplements, medical foods, and pharmaceutical formulations to address folate deficiency, support prenatal health (preventing neural tube defects), and manage conditions like hyperhomocysteinemia and depression.

Brand names
Arcofolin
Other names
Sodium (6S)-5-methyltetrahydrofolate(6S)-5-Methyltetrahydrofolic acid sodium salt5-MTHF-NaL-5-Methyltetrahydrofolate sodiumL5-Methyltetrahydrofolate sodiumL 5-Methyltetrahydrofolate sodium
02

Targets

MTR (Methionine synthase)

Beyond the preview

Go deeper on Arcofolin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Arcofolin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call